Show Summary Details
Page of



Tom Roques

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 January 2021

Curative treatment for locally advanced oesophageal cancer is based around either surgery or radiotherapy. In surgical candidates, neoadjuvant chemotherapy improves 2-year survival by 9%. Concomitant chemoradiotherapy is the standard nonsurgical management of locally advanced oesophageal cancer. There is a growing evidence base for the role of triple modality therapy (chemoradiotherapy followed by surgery). The optimal dose and treatment volumes for radiotherapy in the curative setting are yet to be established. Recurrence of dysphagia after curative radiotherapy may be due to a radiation-induced stricture or to recurrent cancer.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.